Dolutegravir 25 mg and 50 mg and Lithium Citrate Syrup
Determining the interaction of Dolutegravir 25 mg and 50 mg and Lithium Citrate Syrup and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Lithium Controlled-Release and Extended-Release Tablets
- Dolutegravir 25 mg and 50 mg-Lithium ER
- Dolutegravir 25 mg and 50 mg-Lithium Oral Solution
- Dolutegravir 25 mg and 50 mg-Lithium Salts
- Dolutegravir 25 mg and 50 mg-Lithium Syrup and Oral Solution
- Dolutegravir 25 mg and 50 mg-Lithobid
- Lithium Citrate Syrup-Dolutegravir and lamivudine
- Lithium Citrate Syrup-Dolutegravir and rilpivirine
- Lithium Citrate Syrup-Dolutegravir Sodium
- Lithium Citrate Syrup-Dolutegravir Sodium And Lamivudine
- Lithium Citrate Syrup-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Lithium Citrate Syrup-Dom-Etoposide